Interagency Coordination Group on Antimicrobial Resistance

Interagency Coordination Group on Antimicrobial Resistance
Name	Interagency Coordination Group on Antimicrobial Resistance
Formation	2018
Type	Advisory panel
Leader title	Co-chairs
Parent organisation	World Health Organization, Food and Agriculture Organization, World Organisation for Animal Health
Headquarters	Geneva, Rome, Paris

Interagency Coordination Group on Antimicrobial Resistance

The Interagency Coordination Group on Antimicrobial Resistance was an expert advisory body convened by United Nations entities to address antimicrobial resistance through multisectoral policy coordination. It produced technical reports and strategic recommendations linking public health, veterinary medicine, agriculture, trade, and development stakeholders to inform actions by entities such as the World Health Organization, Food and Agriculture Organization, and World Organisation for Animal Health.

Background and Establishment

Established in 2018 following calls from the United Nations General Assembly and informed by reports from The Lancet commissions and the Review on Antimicrobial Resistance chaired by Jim O'Neill, the group responded to mobilization efforts by WHO Director-General Tedros Adhanom Ghebreyesus and leaders at the G20. Its formation built on precedents from the Global Action Plan on Antimicrobial Resistance endorsed by World Health Assembly and policy dialogues at forums including the UN Environment Programme and the World Bank.

Mandate and Objectives

The group's mandate emphasized coordinated guidance across human health and animal health sectors to reduce resistant infections, preserve antibiotics effectiveness, and mitigate economic impacts described in analyses by the Organisation for Economic Co-operation and Development and the International Monetary Fund. Objectives included developing evidence-based recommendations for national action plans, promoting surveillance harmonization consistent with standards from the European Centre for Disease Prevention and Control, and advising on research priorities aligned with funders such as the Wellcome Trust and the Bill & Melinda Gates Foundation.

Membership and Governance

Membership comprised senior representatives and experts from UN agencies including World Health Organization, Food and Agriculture Organization, World Organisation for Animal Health, and observer participants from multilateral institutions such as the World Bank, International Monetary Fund, and regional bodies like the European Commission and African Union. Governance featured co-chairs drawn from technical leaders and advisory panels with inputs from academia represented by institutions such as Harvard University, University of Oxford, and Johns Hopkins University, alongside civil society actors including Médecins Sans Frontières and professional bodies like the Royal Society.

Key Activities and Initiatives

Activities included drafting the group's flagship report outlining prioritized interventions, proposing financing mechanisms similar to those advocated by the Global Fund model, and recommending stewardship programs modeled on initiatives from the Centers for Disease Control and Prevention and national agencies such as the UK Department of Health and Social Care. The group promoted surveillance interoperability using frameworks from the Global Antimicrobial Resistance Surveillance System and convened technical workshops with stakeholders from OIE member countries and research consortia including the Coalition for Epidemic Preparedness Innovations.

Collaborations and Partnerships

The group partnered with international organizations and philanthropic funders—engaging the World Health Organization, Food and Agriculture Organization, World Organisation for Animal Health, World Bank, World Trade Organization, the Wellcome Trust, and foundations linked to Gavi, the Vaccine Alliance. It sought alignment with regional initiatives such as the European Commission's One Health policy, the African Union’s CDC, and bilateral programs supported by countries including United States, United Kingdom, Germany, and Japan.

Impact and Assessments

Reports and recommendations influenced adoption of strengthened national action plans referenced by ministries including the Ministry of Health (United Kingdom), Ministry of Health and Family Welfare (India), and Ministry of Health, Labour and Welfare (Japan). Independent evaluations by think tanks and academic groups cited the group's role in elevating antimicrobial resistance on the UN General Assembly agenda and informing financing proposals in multilateral development banks such as the World Bank. Clinical guidelines and stewardship policies in hospitals overseen by agencies like the Centers for Disease Control and Prevention reflected elements of the group's guidance.

Challenges and Criticisms

Critics—among academic commentators in journals such as The Lancet and policy analysts at institutes like the Chatham House—argued that the group's recommendations required stronger mechanisms for enforcement, sustainable financing, and greater inclusion of low- and middle-income country representatives and civil society organizations such as ActionAid and Oxfam. Implementation barriers cited included fragmented regulatory environments across jurisdictions like the European Union and differing priorities among stakeholders such as pharmaceutical industry associations and agricultural lobby groups.

Category:Public health organizations Category:Antimicrobial resistance